NZ210634A - Purification of recombinant human interleukin - 2; pharmaceutical compositions - Google Patents

Purification of recombinant human interleukin - 2; pharmaceutical compositions

Info

Publication number
NZ210634A
NZ210634A NZ210634A NZ21063484A NZ210634A NZ 210634 A NZ210634 A NZ 210634A NZ 210634 A NZ210634 A NZ 210634A NZ 21063484 A NZ21063484 A NZ 21063484A NZ 210634 A NZ210634 A NZ 210634A
Authority
NZ
New Zealand
Prior art keywords
purification
recombinant human
human interleukin
pharmaceutical compositions
lysis
Prior art date
Application number
NZ210634A
Other languages
English (en)
Inventor
Kung Hsiang-Fu
Yamazaki Shigeko
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ210634A publication Critical patent/NZ210634A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ210634A 1983-12-23 1984-12-19 Purification of recombinant human interleukin - 2; pharmaceutical compositions NZ210634A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56498683A 1983-12-23 1983-12-23

Publications (1)

Publication Number Publication Date
NZ210634A true NZ210634A (en) 1989-05-29

Family

ID=24256731

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ210634A NZ210634A (en) 1983-12-23 1984-12-19 Purification of recombinant human interleukin - 2; pharmaceutical compositions

Country Status (12)

Country Link
EP (1) EP0147819B1 (de)
JP (2) JPH0728753B2 (de)
AT (1) ATE76905T1 (de)
AU (1) AU580276B2 (de)
CA (1) CA1340853C (de)
DE (1) DE3485759D1 (de)
DK (1) DK174501B1 (de)
IE (1) IE57914B1 (de)
IL (1) IL73882A (de)
NZ (1) NZ210634A (de)
PH (1) PH19584A (de)
ZA (1) ZA849910B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
EP0226639B1 (de) * 1985-05-29 1990-11-14 The Green Cross Corporation Herstellungsverfahren für heterogene proteine
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
EP0227833B1 (de) * 1985-07-16 1991-01-16 Green Cross Corporation Verfahren zur herstellung von heteroproteinen
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
EP0337243A1 (de) * 1988-04-14 1989-10-18 F. Hoffmann-La Roche Ag Verfahren zur Reinigung von rekombinantem Interleukin-2
ZA898139B (en) * 1988-11-17 1990-08-29 Hoffmann La Roche Recombinant interleukin-2 hybrid proteins
IT1262981B (it) * 1992-09-09 1996-07-23 Tecnogen Scpa Procedimento per la purificazione della proteina big endotelina
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
JP2006141263A (ja) * 2004-11-18 2006-06-08 Kyoto Univ （ｒ）−ヒドロキシニトリルリアーゼの製造方法
RU2565553C2 (ru) * 2013-04-09 2015-10-20 Общество с ограниченной ответственностью "Стратегия" Способ получения препарата интерлейкина-2, препарат интерлейкина-2 и фармацевтический иммуномодулирующий препарат
CA2954476C (en) * 2014-07-10 2023-09-19 Novartis Ag Immune-stimulating monoclonal antibodies against human interleukin-2
CN116003593A (zh) 2016-01-11 2023-04-25 苏黎世大学 针对人白介素-2的免疫刺激性人源化单克隆抗体及其融合蛋白

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159420A (ja) * 1982-03-18 1983-09-21 Ajinomoto Co Inc インタ−ロイキン２の精製法
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
JPS58198293A (ja) * 1982-05-12 1983-11-18 Shionogi & Co Ltd インタ−ロイキン等免疫調節因子の製造方法
JPS59144719A (ja) * 1983-02-03 1984-08-18 Japan Found Cancer ヒトインタ―ロイキン２活性を有するポリペプチド
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
DK612484A (da) 1985-06-24
EP0147819A2 (de) 1985-07-10
DK174501B1 (da) 2003-04-28
JPH0728753B2 (ja) 1995-04-05
PH19584A (en) 1986-05-26
DK612484D0 (da) 1984-12-19
AU580276B2 (en) 1989-01-12
JPH07233082A (ja) 1995-09-05
CA1340853C (en) 1999-12-21
ZA849910B (en) 1985-09-25
IE57914B1 (en) 1993-05-19
JPS60172295A (ja) 1985-09-05
DE3485759D1 (de) 1992-07-09
IL73882A (en) 1989-05-15
EP0147819A3 (en) 1987-09-23
EP0147819B1 (de) 1992-06-03
IE843320L (en) 1985-06-23
ATE76905T1 (de) 1992-06-15
IL73882A0 (en) 1985-03-31
AU3699584A (en) 1985-07-04
JP2864996B2 (ja) 1999-03-08

Similar Documents

Publication Publication Date Title
NZ210634A (en) Purification of recombinant human interleukin - 2; pharmaceutical compositions
IT1164626B (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
PH21012A (en) Process for recovering microbially produced interleukin-2 and purified recombinant interleukin 2 compositions
IL69731A0 (en) Homogeneous human interleukin 2,its preparation and pharmaceutical compositions containing it
GR78575B (de)
NZ192991A (en) Preparation of purified protein hydrolysate
PT80247A (en) Stable composition of interleukin-2
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
AU556112B2 (en) Pharmaceutical compositions of buspirone
AU581010B2 (en) Novel pharmaceutical use of (NVA)``-cyclosporine
EP0149551A3 (de) Synergistische Gamma-Interferon-Interleukin-2-Zusammensetzungen und Verfahren zur Herstellung desselben
IL67978A0 (en) Human immune interferon,its preparation and purification and pharmaceutical compositions containing it
AU4482985A (en) Pyrro-1-yl-phenyl-dihydropyridazones
PH21165A (en) Novel phenol naphthyridines and pharmaceutical composition containing thereof
ES8706138A1 (es) Procedimiento para la obtencion de nuevas benzoilureas
IE55801B1 (en) Novel vitamin d analogs
IL83594A0 (en) Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it
AU6610086A (en) Phenylacetaldehydes substituted by basic groups, their preparation and drugs containing these compounds
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
AU551840B2 (en) Pharmaceutical compositions containing an extract of mandassi
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
ZA857053B (en) Pharmaceutical compositions of microbially produced interleukin-2